A retrospective analysis of extended-interval dosing and the impact on bisphosphonate compliance in the US Military Health System

Improved GI Tolerability with Monthly Ibandronate in Women Previously Using Weekly Bisphosphonates

(2011) Neil Binkley et al.   SOUTHERN MEDICAL JOURNAL

Adoption of Once-monthly Oral Bisphosphonates and the Impact on Adherence

(2010) Becky A. Briesacher et al.   AMERICAN JOURNAL OF MEDICINE

Atypical Fractures as a Potential Complication of Long-term Bisphosphonate Therapy

(2010) Deborah E. Sellmeyer   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prolonged antiresorptive activity of zoledronate: A randomized, controlled trial

(2010) Andrew Grey et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Management of glucocorticoid-induced osteoporosis

(2010) Juliet Compston   Nature Reviews Rheumatology

Oral bisphosphonate compliance and persistence: a matter of choice?

(2010) S. L. Silverman et al.   OSTEOPOROSIS INTERNATIONAL

Risk of Severe Gastrointestinal Events in Women Treated with Monthly Ibandronate or Weekly Alendronate and Risedronate

(2009) William A Blumentals et al.   ANNALS OF PHARMACOTHERAPY

Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence

(2009) Véronique Rabenda et al.   EXPERT OPINION ON PHARMACOTHERAPY

Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women

(2009) Dana Bliuc   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Patient Satisfaction in Postmenopausal Women Treated with a Weekly Bisphosphonate Transitioned to Once-Monthly Ibandronate

(2009) Sydney Lou Bonnick et al.   JOURNAL OF WOMENS HEALTH

Medication Compliance and Persistence: Terminology and Definitions

(2007) Joyce A. Cramer et al.   VALUE IN HEALTH